Agartha DUO 50 mg + 850 mg Tabletki powlekane Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

agartha duo 50 mg + 850 mg tabletki powlekane

gedeon richter polska sp. z o.o. - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg

Agartha DUO 50 mg + 1000 mg Tabletki powlekane Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

agartha duo 50 mg + 1000 mg tabletki powlekane

gedeon richter polska sp. z o.o. - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg

Zomarist Unia Europejska - polski - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - вилдаглиптин, metformina chlorowodorek - diabetes mellitus, type 2 - leki stosowane w cukrzycy - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Agnis Combi 50 mg + 1000 mg Tabletki powlekane Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

agnis combi 50 mg + 1000 mg tabletki powlekane

belupo lijekovi i kozmetika d.d. - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg

Agnis Combi 50 mg + 850 mg Tabletki powlekane Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

agnis combi 50 mg + 850 mg tabletki powlekane

belupo lijekovi i kozmetika d.d. - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg

Eucreas Unia Europejska - polski - EMA (European Medicines Agency)

eucreas

novartis europharm limited - вилдаглиптин, metformina chlorowodorek - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.